Ten Bio News
The future of wearable technologies in skin research
Wearable technologies are evolving into platforms that generate continuous insight into skin health and underlying physiology. As devices become more biologically integrated, skin is emerging as a critical interface — shaping what wearables can measure and how reliably they perform. This article explores where skin-interfacing wearables are heading and how TenSkin™ helps bridge early development and real-world use.
Understanding eczema: Beyond symptoms
Eczema (atopic dermatitis) affects millions worldwide, yet many of its underlying mechanisms are still being uncovered. In this article, Professor Alan Irvine outlines what science understands about the condition’s causes — from the role of the skin barrier and immune pathways to the influence of the microbiome and environment — and explains how these insights are shaping innovative approaches to prevention and treatment.
Bridging the gap: Comparing topical drug absorption and activity in mouse and human skin models
Mouse models remain a cornerstone of dermatology research, but their differences from human skin — in follicle density, barrier function, and wound healing — can limit translation. This article explores the critical factors that shape absorption and pharmacological activity, and considers how human-based models can improve predictive power.
Why psoriasis research needs a human-relevant approach — and how ex vivo models can deliver
Explore how TenSkin™, Ten Bio’s ex vivo human skin model, is helping researchers study psoriasis with greater accuracy and human relevance — reducing reliance on animal testing and improving translational outcomes.
A season of global engagement in skin science and innovation
This spring, Ten Bio joined leading voices in dermatology at events in France, the US, and Australia—spotlighting TenSkin™ as a powerful, human-relevant alternative to animal testing. From photoprotection to microneedle delivery, the message was clear: innovation needs better models.
Ten Bio joins James Hutton Institute’s Dundee campus to advance dermatological research
Ten Bio has officially joined the James Hutton Institute’s Dundee campus, marking a new chapter in its mission to advance human-relevant dermatology research. The move supports Ten Bio’s continued growth and fosters collaboration with one of Scotland’s leading scientific communities.
Predicting human response to gene-based therapies in preclinical evaluation
Why do so many gene therapies fail in clinical trials? A closer look at the preclinical gap—and how TenSkin™ is helping close it.
Beyond animal models: The future of skin testing is human-relevant and ready
As regulatory momentum builds and new human-relevant technologies emerge, the conversation is shifting. The question is no longer if we can replace animal testing in skin research — but how fast. This article explores why models like TenSkin™ offer a scalable, scientifically robust alternative that’s already reshaping preclinical research.
Setting the standard: How TenSkin is shaping regulatory change in skin testing
As regulators move away from animal testing, clear validation frameworks are needed to support alternatives. Explant models like TenSkin™ offer a human-relevant solution for preclinical skin research, improving predictability and reproducibility.
Pollution protection
Urban pollution drives demand for advanced skincare. Ten Bio’s TenSkin™ offers a next generation ex vivo model to test anti-pollution products, providing crucial insights that accelerate the development of scientifically validated, high-impact solutions.
The future of wearable technologies in skin research
Wearable technologies are evolving into platforms that generate continuous insight into skin health and underlying physiology. As devices become more biologically integrated, skin is emerging as a critical interface — shaping what wearables can measure and how reliably they perform. This article explores where skin-interfacing wearables are heading and how TenSkin™ helps bridge early development and real-world use.
Understanding eczema: Beyond symptoms
Eczema (atopic dermatitis) affects millions worldwide, yet many of its underlying mechanisms are still being uncovered. In this article, Professor Alan Irvine outlines what science understands about the condition’s causes — from the role of the skin barrier and immune pathways to the influence of the microbiome and environment — and explains how these insights are shaping innovative approaches to prevention and treatment.
Bridging the gap: Comparing topical drug absorption and activity in mouse and human skin models
Mouse models remain a cornerstone of dermatology research, but their differences from human skin — in follicle density, barrier function, and wound healing — can limit translation. This article explores the critical factors that shape absorption and pharmacological activity, and considers how human-based models can improve predictive power.
Why psoriasis research needs a human-relevant approach — and how ex vivo models can deliver
Explore how TenSkin™, Ten Bio’s ex vivo human skin model, is helping researchers study psoriasis with greater accuracy and human relevance — reducing reliance on animal testing and improving translational outcomes.
A season of global engagement in skin science and innovation
This spring, Ten Bio joined leading voices in dermatology at events in France, the US, and Australia—spotlighting TenSkin™ as a powerful, human-relevant alternative to animal testing. From photoprotection to microneedle delivery, the message was clear: innovation needs better models.
Ten Bio joins James Hutton Institute’s Dundee campus to advance dermatological research
Ten Bio has officially joined the James Hutton Institute’s Dundee campus, marking a new chapter in its mission to advance human-relevant dermatology research. The move supports Ten Bio’s continued growth and fosters collaboration with one of Scotland’s leading scientific communities.